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Epstein-Barr virus (EBV) is a human oncogenic herpesvirus associated with epithelial cell and B-cell
malignancies. EBV infection of B lymphocytes is essential for acute and persistent EBV infection in humans;
however, the role of epithelial cell infection in the normal EBV life cycle remains controversial. The rhesus
lymphocryptovirus (LCV) is an EBV-related herpesvirus that naturally infects rhesus macaques and can be
used experimentally to model persistent B-cell infection and B-cell lymphomagenesis. We now show that the
rhesus LCV can infect epithelial cells in immunosuppressed rhesus macaques and can induce epithelial cell
lesions resembling oral hairy leukoplakia in AIDS patients. Electron microscopy, immunohistochemistry, and
DNA-RNA in situ hybridization were used to identify the presence of a lytic rhesus LCV infection in these
proliferative, hyperkeratotic, or parakeratotic epithelial cell lesions. These studies demonstrate that the rhesus
LCV has tropism for epithelial cells, in addition to B cells, and is a relevant animal model system for studying
the role of epithelial cell infection in EBV pathogenesis.
Epstein-Barr virus (EBV) can infect both lymphocytes and
epithelial cells. EBV infection of B lymphocytes is a key step in
the pathogenesis of acute EBV infection, persistent EBV in-
fection, and EBV-associated B-cell malignancies (4, 7). The
role of epithelial cell infection in EBV biology is more contro-
versial. The association of EBV infection with nasopharyngeal
and gastric carcinomas clearly demonstrates that EBV can
infect epithelial cells, and latent EBV infection is believed to
contribute to the malignant transformation of epithelial cells in
these instances (14, 21, 23, 25). EBV infection and lytic repli-
cation in lingual epithelial cells can also cause oral hairy leu-
koplakia in immunosuppressed AIDS patients (8). However, it
is less certain whether EBV infection of epithelial cells is a
routine, or required, component of the virus life cycle in all
individuals or whether EBV infection of epithelial cells is an
atypical event associated with immunosuppression or an in-
creased risk of oral malignancies.
The traditional paradigm for primary EBV infection places
virus infection and replication in oral epithelial cells as a crit-
ical step between oral inoculation of virus and invasion of the
peripheral blood B-cell compartment (22). However, this
model has been challenged by the inability to detect EBV
infection in the tonsillar epithelium of infectious mononucle-
osis patients (10, 13). This has led some to speculate that EBV
infection of epithelial cells is not an important step for primary
EBV infection and that orally inoculated virus may bypass
epithelial cells and directly infect B cells. The apparent lack of
persistent EBV infection and virus in oral secretions of pa-
tients with X-linked agammaglobulinemia who lack B cells is
also consistent with the possibility that epithelial cell infection
is not important and that the principal source of infectious
EBV in oral secretions is from EBV-infected B cells in tonsillar
tissue rather than infected epithelial cells (4).
Other explanations may contribute to the apparent inability
to detect EBV infection in epithelial cells of immunocompe-
tent hosts. The tonsil may not be the optimal site for EBV
infection of oral epithelium, and patients presenting with clin-
ically advanced infectious mononucleosis requiring tonsillec-
tomy may be beyond the optimal time points for peak epithe-
lial cell infection. Persistent EBV infection in epithelial cells
may be cryptic in immunocompetent hosts, with only occa-
sional latently infected cells dispersed in various anatomical
locations. Patterns of viral gene expression may be different in
epithelial cells than in B cells. For example, in situ hybridiza-
tion (ISH) for the abundant small EBV-encoded RNAs
(EBERs) is frequently used as a sensitive assay for EBV in-
fection in B cells, but EBERs are not commonly expressed in
the EBV-infected epithelial cells of oral hairy leukoplakia (6).
Reactivation of lytic EBV infection in epithelial cells should
result in easily detectable viral gene expression, but reactiva-
tion may be occurring in sites that are difficult to access and
biopsy in otherwise healthy individuals. Thus, it remains un-
certain whether epithelial cell infection with EBV is a normal
component of the acute and persistent EBV life cycle.
Studies of nonhuman primate herpesviruses closely related
to and in the same lymphocryptovirus (LCV) genus as EBV
can provide an animal model system to study EBV pathogen-
esis (12). The rhesus LCV genome has been completely se-
quenced, and the viral gene repertoire is identical to that of
EBV (18). Like EBV, the rhesus LCV efficiently immortalizes
B cells in tissue culture (15). As is the case for humans, nearly
all rhesus monkeys raised in conventional domestic colonies
* Corresponding author. Mailing address: Channing Laboratory,
181 Longwood Ave., Boston, MA 02115. Phone: (617) 525-4258. Fax:
(617) 525-4257. E-mail: fwang@rics.bwh.harvard.edu.
† Present address: Charles River Laboratories, Wilmington, Mass.
3455
have a persistent, asymptomatic rhesus LCV infection that can
be detected in the peripheral blood lymphocytes of healthy,
seropositive animals (16). Rhesus LCV is also associated with
the development of B-cell lymphomas in immunosuppressed
monkeys (9, 15). Thus, there is considerable genetic and bio-
logic evidence that rhesus LCV infection of B cells is very
similar to EBV infection. Viral DNA can be detected in the
oral secretions of persistently infected monkeys, and naive
rhesus macaques can be successfully infected by experimental
oral virus inoculation, suggesting that the mode of transmission
is also similar to that of EBV infection in humans (12). How-
ever, to date there has been no definitive evidence that the
rhesus LCV can infect epithelial cells. In the present study,
we describe naturally occurring rhesus LCV-infected epithelial
cell lesions in immunosuppressed macaques that resemble oral
hairy leukoplakia. These studies demonstrate that like EBV,
rhesus LCV has tropism for both B cells and epithelial cells in
vivo and that this animal model system should be useful for
exploring the role of epithelial cells in EBV infection.
MATERIALS AND METHODS
Animals. Histopathologic reports for 585 simian immunodeficiency virus
(SIV)-infected rhesus macaques necropsied between 1997 and 2002 at the New
England Primate Research Center were reviewed, and eight cases with balloon-
ing degeneration of mucosal or epidermal epithelial cells containing intranuclear
inclusion bodies suggestive of herpesvirus infection were identified. All ma-
caques were assigned to studies funded by the National Institutes of Health
that were conducted in accordance with federal and institutional guidelines
for animal care. The monkeys in this report were experimentally inoculated
with SIVmac251, SIVmac239, SIVM5, or SIVmac239/YE, which have been
previously described (3, 11, 17). Briefly, SIVmac251 is an uncloned pathogenic
virus. SIVmac239 is a molecularly cloned pathogenic virus, SIVM5 lacks five
N-glycan attachment sites from SIVmac239 Env, and SIVmac239/YE has two
amino acid changes in the Nef region of SIVmac239. All animals in this study
acquired LCV infection naturally. The macaques were euthanized either at the
study endpoint or on the basis of established criteria for SIV-infected macaques
with end-stage AIDS. Thorough necropsies were performed, and tissue speci-
mens of all organs were collected for fixation in 10% buffered formalin.
Electron microscopy. A 5.0-m section of formalin-fixed esophagus (A02-303)
immunostained with anti-BZLF1 was processed for transmission electron mi-
croscopy as previously described (2). In brief, toluene was used to remove the
coverslip and in the preparation of the fixative and resin. The fixed tissue was
postfixed in 1% osmium tetroxide (Stevens Metallurgical Corp., New York,
N.Y.), dehydrated, and embedded in eponate 12 resin (Ted Pella, Redding,
Calif.). Ultrathin sections were cut on a Leica Ultracut R ultramicrotome and
stained with uranyl acetate and Sato’s lead stain (19). The sections were exam-
ined on a JEOL 1010 transmission electron microscope.
Rhesus LCV serology. Serum antibodies to the rhesus LCV small viral capsid
antigen (sVCA) were detected by using an sVCA peptide enzyme immunoassay
as previously described (16).
EBER ISH. RNA ISH for EBER expression was performed as previously
described (20).
CISH. Chromogenic ISH (CISH) for the presence of LCV DNA was per-
formed on formalin-fixed, paraffin-embedded tissue after pretreatment with
methanol–0.5% peroxide for 20 min followed by proteinase K (1:5 dilution;
Dako, Carpinteria, Calif.) at room temperature for 10 min. Rhesus LCV cosmids
CC1, QA15, and LV28 (18) were mixed in equal portions, and the rhesus LCV
DNA was labeled with digoxigenin (Roche). Hybridization with the digoxigenin-
labeled rhesus LCV DNA probe was carried out for 10 min at 75°C followed by
4 h at 37°C. Slides were washed three times and incubated with 10% goat serum
in 50 mM Tris-Cl (pH 7.4) for 20 min to block nonspecific binding sites. Next,
rabbit antidigoxigenin (1:150 dilution; Dako) was applied in 50 mM Tris-HCl
(pH 7.4) with 3% goat serum at room temperature for 1 h. Slides were washed
in 50 mM Tris-HCl (pH 7.4), and goat anti-rabbit horseradish peroxidase-con-
jugated antibody (Envision detection kit; Dako) was applied for 30 min. After
further washing, immunoperoxidase staining was developed by using a diamino-
benzidine (DAB) chromogen kit (Dako) according to the instructions of the
manufacturer and counterstained with methyl green counterstain.
Anti-BZLF1 and anti-EBNA-2 immunohistochemistry. Immunohistochemis-
try for LCV immediate-early viral lytic protein (BZLF1, clone BZ.1; Dako) and
EBV-encoded nuclear antigen 2 (EBNA-2, clone PE2; Dako) was performed on
5.0-m sections from formalin-fixed, paraffin-embedded tissues. Both antibodies
are known to cross-react with the respective rhesus LCV homologues based on
the detection of an appropriately sized protein by Western blot analysis of cells
transfected with recombinant expression plasmids and expression of the respec-
tive recombinant rhesus LCV genes. The sections were deparaffinized and rehy-
drated. Endogenous peroxidase activity was quenched with a hydrogen peroxide
block for 5 min. Antigen retrieval was achieved by microwaving for 20 min. The
sections were treated with Dako Protein Block for 10 min and incubated at 4°C
overnight with the primary antibody (BZLF1 diluted 1:80 or EBNA-2 diluted
1:6400). The secondary antibody, biotinylated horse anti-mouse immunoglobulin
G (Vector Laboratories, Burlingame, Calif.) diluted 1:200, was applied for 30
min, followed by a 30-min incubation with Vectastain ABC Elite. The reaction
was visualized by using DAB chromogen (Dako), and the slides were counter-
stained with Mayer’s hematoxylin.
Anti-sVCA immunohistochemistry. Immunohistochemistry for LCV sVCA
(anti-sVCA-p18; BFRF3) was performed with 5.0-m-thick formalin-fixed, par-
affin-embedded tissue sections. Briefly, slides were deparaffinized and pretreated
with 10 mM sodium citrate buffer (pH 6.0) (Zymed, South San Francisco, Calif.)
in a steam pressure cooker (Decloaking Chamber; BioCare Medical, Walnut
Creek, Calif.) according to the manufacturer’s instructions, followed by washing
in distilled water. All further steps were performed at room temperature in a
hydrated chamber. Slides were pretreated with Peroxidase Block (Dako) for
5 min to quench endogenous peroxidase activity followed by a 1:5 dilution of goat
serum in 50 mM Tris-HCl (pH 7.4) for 20 min to block nonspecific binding sites.
Primary rat anti-sVCA antibody (OT15E, anti-sVCA-p18) (BFRF3; Cyto-Barr
BV, Bergen, The Netherlands) was applied at a 1:250 dilution in 50-mM Tris-
HCl (pH 7.4) with 3% goat serum for 1 h. After washing in 50 mM Tris-HCl (pH
7.4), secondary rabbit anti-rat antibody (Dako) was applied at a 1:7,500 dilution
in 50 mM Tris-HCl (pH 7.4) with 3% goat serum for 30 min. Slides were washed
again in 50 mM Tris-HCl (pH 7.4), and goat anti-rabbit horseradish peroxidase-
conjugated antibody (Envision detection kit; DAKO) was applied for 30 min.
After further washing, immunoperoxidase staining was developed by using a
DAB chromogen kit (Dako) according to the instructions of the manufacturer
and counterstained with Harris hematoxylin.
RESULTS
Epithelial abnormalities suggestive of viral infection were
noted by light microscopic examination of hematoxylin- and
eosin-stained sections from routine necropsies of SIV-infected
rhesus macaques at the New England Primate Research Cen-
ter from 1997 to 2002. These lesions were found most fre-
quently within the mucosal tissues of the upper digestive tract
(tongue in four cases and esophagus in five cases); however, in
one case (A98-563), a hyperkeratotic lesion of the skin of the
penis was grossly apparent (Table 1). Similar lesions have not
been observed in routine necropsies of immunocompetent an-
imals. The histologic findings were similar to those seen in oral
hairy leukoplakia, a proliferative epithelial cell lesion most
frequently seen on the tongue and associated with EBV infec-
tion in AIDS patients (8). The macaque epithelial cell lesions
were characterized by irregularities or corrugations in a hyper-
plastic epithelium with mounds of parakeratotic cells at the
tips of prominent papillae (Fig. 1A). Within the prickle and
functional cell layers of the esophagus or stratum spinosum of
the epidermis, a patchy band of lightly stained “balloon cells”
or koilocytes was present (Fig. 1A and B). Nuclei within these
koilocytic cells demonstrated markedly condensed chromatin
with vacuolization of the surrounding nucleoplasm. No obvious
abnormality in the basal epithelial cell layer was identified, and
accompanying inflammation was not present.
Sections from A02-303 were examined by electron micros-
copy to identify potential virus particles. High magnification of
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a cell nucleus from the prickle cell layer (Fig. 1C) shows mar-
ginated chromatin in a nucleus filled with nucleocapsids com-
patible in size (approximately 100 nm) with a herpesvirus.
Structures resembling enveloped virions with a size of approx-
imately 160 nm were visible in regions consistent with the
interdigitating cytoplasmic processes of adjacent epithelial
cells (Fig. 1D). Thus, electron microscopy confirmed the pres-
ence of marginated chromatin, nucleocapsids, and enveloped
viruses consistent with an active herpesvirus infection.
Since the hyperplastic mucosal epithelium and evidence for
active herpesvirus infection were reminiscent of oral hairy leu-
koplakia, additional studies were focused on definitively iden-
tifying whether infection with an EBV-related herpesvirus was
associated with the macaque epithelial lesions. Testing of avail-
able serum samples showed that all animals had serologic
evidence of infection with the EBV-related LCV that naturally
infects rhesus macaques (Table 1). Histologic sections were
stained with an EBV BZLF1 monoclonal antibody that was
known to cross-react with the rhesus LCV BZLF1 homologue.
All lesions were positive for the immediate-early viral lytic
protein, BZLF1 (Fig. 1E and Table 1). To provide confirma-
tion and further characterization of lytic infection in these
lesions, a second monoclonal antibody, OT15E, which is spe-
cific for the EBV sVCA, was identified based on its ability to
cross-react with an 18-kDa protein in rhesus LCV-infected
cells induced for lytic viral replication (data not shown). Im-
munohistochemistry with the OT15E antibody showed strong
expression of sVCA in all lesions examined, demonstrating
active lytic infection throughout the histologically abnormal
areas of all lesions (Fig. 1F and 2B, D, F, and H; Table 1). Both
BZLF1 and sVCA antibodies detected viral gene expression in
virtually all cells with intranuclear inclusions and were re-
stricted to cells in the upper stratified epithelium. There was a
sharp demarcation with no staining of adjacent normal epithe-
lium, and control sections from animals without epithelial cell
lesions did not stain with the BZLF1 and sVCA antibodies,
demonstrating the specificity of the immunohistochemical
staining (Fig. 2J).
Infection with rhesus LCV was also confirmed by DNA ISH
with cloned rhesus LCV DNA probes. Cells with intranuclear
inclusions were strongly positive by DNA ISH, consistent with
viral DNA replication (Fig. 1G and H and 2A, C, E, and G).
Histologically normal epithelium was negative (Fig. 2I). DNA
ISH with the rhesus LCV DNA probes is specific for rhesus
LCV infection, cross-reacting only weakly with EBV-infected
cells and not at all with cells infected with the closely related
gamma-2 herpesvirus rhesus rhadinovirus (data not shown).
DNA CISH and immunohistochemistry (BZLF1 and sVCA)
generally stained identical areas of abnormal epithelial cell
histology; i.e., most cells were positive for LCV DNA, BZLF1,
and sVCA expression (Fig. 2). DNA CISH and sVCA immu-
nohistochemistry showed a gradient of increasing intensity in
the upper levels of the stratified epithelium, consistent with
progressive lytic infection (Fig. 1F and G and 2), and BZLF1
expression was generally more uniform throughout the epithe-
lial cell layers (Fig. 1E and data not shown). Thus, in five cases,
there is strong expression of an immediate-early lytic viral
protein, a structural viral capsid protein, and abundant viral
DNA, which definitively identify an active rhesus LCV infec-
tion in these epithelial cell lesions. There was no convincing
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FIG. 1. Morphological, electron microscopic, and viral phenotypic findings for a representative mucosal lesion in an SIV-infected rhesus
macaque (A02-303). (A and B) Hematoxylin- and eosin-stained section of a mucosal lesion with hyperparakeratosis and prominent balloon cells
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evidence for latent LCV infection in the more undifferentiated
cells of the basal layer, i.e., cells that were positive for an epi-
somal pattern of viral DNA and negative for BZLF1 expres-
sion; however, at this time, technical issues limit the ability to
perform DNA CISH and BZLF1 immunohistochemistry on
the same tissue sections, and rare cells of this type may be
missed by studies of serial tissue sections.
Five of seven lesions were also positive for EBNA-2 expres-
sion by using a monoclonal antibody that is known to detect a
conserved epitope in the carboxy-terminal acidic transactivat-
ing domain of the EBV, baboon, and rhesus LCV EBNA-2
homologues (Table 1). EBNA-2 is an EBV latent infection
protein and is not typically associated with lytic replication.
However, aberrant EBNA-2 expression has also been de-
scribed in association with active viral replication in oral hairy
leukoplakia (24). ISH for the rhesus LCV EBER homologues
was negative in five of six cases, and in one case epithelial cells
were positive for EBER expression (Table 1). These small,
nonpolyadenylated RNAs are typically expressed at very high
copy numbers in latently infected cells, and EBER ISH is
commonly used to detect EBV infection in tissue sections.
However, the frequent lack of EBER expression in the rhesus
epithelial cell lesions is similar to the lack of EBER expression
reported in EBV-associated oral hairy leukoplakia from AIDS
patients (6). In addition, EBER ISH, EBNA-2 immunohisto-
chemistry, and DNA CISH failed to detect LCV-positive lym-
phocytes infiltrating the subepithelial cell layers associated
with these lesions.
DISCUSSION
These are the first studies to unequivocally identify that
rhesus LCV can infect and is associated with disease in epi-
thelial cells. These studies show that the rhesus LCV is similar
to EBV, with cell tropism and a disease spectrum that includes
epithelial cells, in addition to B lymphocytes. The role of epi-
thelial cell infection in the normal life cycle of EBV infection
is controversial. EBV infection can clearly spread to and cause
disease in epithelial cells, but whether EBV routinely infects
and persists in epithelial cells in healthy, immunocompetent
hosts is unclear. The presence of rhesus LCV infection in
epithelial cells demonstrates that the epithelial cell tropism is
not peculiar to EBV infection of humans but is likely shared by
other EBV-related herpesviruses in the LCV genus.
The histologic appearance of these proliferative, hyperker-
atotic, and parakeratotic epithelial cell lesions is very similar to
that of oral hairy leukoplakia in AIDS patients. The electron
microscopic appearance, immunohistochemical staining for an
immediate-early protein and a viral capsid protein, and strong
DNA ISH clearly demonstrate the association of these epithe-
lial cell lesions with rhesus LCV infection in multiple cases.
Furthermore, they characterize the rhesus LCV infection as an
active lytic process in the lesions, similar to that of EBV in-
fection in oral hairy leukoplakia. Baskin et al. had previously
observed squamous epithelial lesions with intranuclear inclu-
sions in eight SIV-infected macaques (1). Hyperkeratosis and
acanthosis were present in lesions on external epithelial cell
surfaces (e.g., penis, chest skin, and hand), and lesions on
internal epithelial surfaces (e.g., tongue and esophagus) were
characterized by intranuclear inclusions and ballooning degen-
eration but without hyperkeratosis. Bacterial and fungal infec-
tions with inflammation were also frequently found associated
with these lesions. The data implicating infection with an EBV-
related herpesvirus were limited to one of four tissue samples
that stained with a monoclonal antibody against the EBV
LMP1 protein and positive DNA ISH with a 3.1-kb EBV DNA
probe in one of three cases. In our hands, the EBV LMP1
monoclonal antibodies do not cross-react with the rhesus LCV
LMP1 homologue. In addition, the rhesus LCV genome se-
quence reveals that the LMP1 gene is one of the least well-
conserved genes between EBV and rhesus LCV, with no sig-
nificant amino acid homology in the carboxy terminus targeted
by various EBV LMP1 monoclonal antibodies (5). Overall, the
virologic data linking an EBV-related herpesvirus to these
lesions were limited. We did not find any characteristic epithe-
lial cell lesions that failed to test positive for rhesus LCV DNA,
but we cannot rule out the possibility that other viruses or
pathogens may be associated with similar lesions in immuno-
suppressed hosts.
The presence of lesions on external epithelial cell surfaces
suggests that infection may have occurred as a result of biting
and secondary infection from oral secretions containing virus.
In six of seven of our cases, the rhesus LCV-positive lesions
occurred on internal sites, i.e., in the esophagus and/or tongue,
eliminating self-induced trauma as a potential portal of infec-
tion. The frequent involvement of the esophagus in SIV-in-
fected macaques raises the question of whether this might also
be a common site for EBV-induced epithelial cell abnormali-
ties in AIDS patients. At these internal sites, epithelial cell
infection most likely originated from viremia and infection
through the basal epithelial cell surfaces, but one cannot rule
out the possibility of infection from virus in oral secretions
bathing and infecting the apical epithelial cell surface. The
DNA ISH technique used here has the sensitivity to detect
single-copy episomes in paraffin-embedded tissue (J. L. Kutok
et al., unpublished data). Thus, it is interesting that no low-
copy viral infection was noted in the basal epithelial cell layers,
suggesting that these lesions are not associated with persistent,
latent rhesus LCV infection in the basal epithelium.
Multiple questions regarding EBV infection of epithelial
cells in immunocompetent, healthy hosts remain unresolved.
Are oral epithelial cells the first cells infected with incoming
within the upper epithelial cell layers. Magnifications, 100 (A) and 400 (B). (C) Transmission electron micrograph showing the nucleus of a
degenerative mucosal epithelial cell undergoing karyolysis with marginated chromatin (long arrow) and numerous intranuclear herpesvirus
nucleocapsids (short arrow). The arrowhead indicates the nuclear membrane. Bar, 200 nm. (D) Transmission electron micrograph showing an area
of mucosa revealing herpesvirus virions (arrows) within the intercellular spaces between interdigitating cytoplasmic projections (arrowheads) of
adjacent epithelial cells. Bar, 500 nm. The inset shows a higher magnification of virions which measure 160 nm in diameter. (E and F)
Immunohistochemical staining showing expression of BZLF1 (magnification, 400) (E) and sVCA (magnification, 50) (F). (G and H) CISH
demonstrating strong nuclear staining with a probe specific for LCV DNA. Magnifications, 50 (G) and 400 (H).
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FIG. 2. CISH for LCV DNA (A, C, E, G, and I) and immunohistochemical staining for sVCA (anti-sVCA-p18; BFRF3) (B, D, F, H, and J)
in epithelial lesions from SIV-infected rhesus macaques A01-643 (A and B), A02-563 (C and D), A98-563 (E and F), and A99-75 (G and H) and
in control nonlesional tissue from macaque A98-118 (I and J). Magnifications, 100 (A, C, D, F, G, and H), 50 (B and I), and 200 (E and J).
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virus in primary EBV infection? Is viral replication in oral
epithelial cells required for entry into the peripheral blood
compartment during primary EBV infection? Does EBV per-
sist and latently infect oral epithelial cells in convalescent,
seropositive hosts? Is viral replication in oral epithelial cells
the source of virus shed in the oral secretions of persistently
infected hosts? The rhesus LCV model can be helpful for
investigating these questions by allowing for more thorough
dissection of the oral and upper digestive tracts of naturally
and experimentally infected animals to search for reservoirs of
virus infection. In addition, the experimental rhesus LCV
model is conducive for kinetic studies immediately after viral
infection, whereas studies with humans are limited to clinical
presentation with infectious mononucleosis as the earliest time
point for potential study. The development of genetic systems
for rhesus LCV will provide an experimental system for study-
ing alterations in viral genes that may affect epithelial cell
infection or for using markers to more easily identify isolated
foci of viral infection. The development of reagents and probes
to detect rhesus LCV infection will be particularly important
for detecting reservoirs of LCV infection in the oral cavity, as
these sites are likely to be subtle in immunocompetent hosts.
The complete rhesus LCV genome sequence is useful for
identifying well-conserved targets where existing EBV-specific
monoclonal antibodies, e.g., the EBV BZLF1 and sVCA mono-
clonal antibodies used in the present studies, might cross-react.
In addition, the development of a sensitive rhesus LCV DNA
ISH assay for paraffin-embedded tissue provides an important
assay for detection of low-copy rhesus LCV infection indepen-
dent of viral gene expression. These are important new tools
for demonstrating epithelial cell tropism in rhesus LCV infec-
tion and will aid in the use of this model system to investigate
the role of epithelial cell infection in EBV pathogenesis.
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